1. Home
  2. CMCO vs CATX Comparison

CMCO vs CATX Comparison

Compare CMCO & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbus McKinnon Corporation

CMCO

Columbus McKinnon Corporation

HOLD

Current Price

$14.81

Market Cap

429.4M

Sector

Industrials

ML Signal

HOLD

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

HOLD

Current Price

$3.01

Market Cap

497.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCO
CATX
Founded
1875
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
429.4M
497.9M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
CMCO
CATX
Price
$14.81
$3.01
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$21.00
$12.11
AVG Volume (30 Days)
667.4K
1.4M
Earning Date
05-27-2026
05-11-2026
Dividend Yield
1.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$936,240,000.00
N/A
Revenue This Year
$19.73
N/A
Revenue Next Year
$82.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.27
N/A
52 Week Low
$11.99
$1.96
52 Week High
$24.40
$6.16

Technical Indicators

Market Signals
Indicator
CMCO
CATX
Relative Strength Index (RSI) 51.65 30.66
Support Level $14.03 $2.94
Resistance Level $16.16 $2.96
Average True Range (ATR) 0.99 0.21
MACD 0.08 -0.02
Stochastic Oscillator 68.35 8.68

Price Performance

Historical Comparison
CMCO
CATX

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: